MIA joins Sydney Health Partners
MIA has joined Sydney Health Partners, with a shared focus on more rapidly translating research evidence into patient benefit.
MIA has joined Sydney Health Partners, with a shared focus on more rapidly translating research evidence into patient benefit.
A promising young MIA researcher is conferred with University of Sydney PhD.
Cited an incredible 427 times around the world, showing its vital role in improving outcomes for people with advanced melanoma.
The 'Distinguished Alumni Award' from University of Tasmania honours the exceptional impact of his work around the world.
The 'Outstanding Research Award' recognises their life-saving discoveries transforming melanoma patient care.
The award recognises her pioneering work in immunotherapy in melanoma, transforming the care of patients worldwide.
The highly anticipated annual list is the “who’s who” of the scientific elite from across the globe.
New research shows routine skin checks by a health professional, plus checking your own skin, are vital in saving lives from melanoma.
Drug therapy looks set to become the standard treatment for high-risk early stage melanoma patients.
“The future looks bright – I truly believe that we will get to zero deaths from melanoma with the trajectory we’re following.”